Furthermore, compound 7k exhibited selective cytotoxicity against colorectal cancer cells and induced apoptosis via p53/p21/caspase 3 signaling, thereby leading to in vivo antitumor activity when orally administered as a single agent. The gene discussed is TP53; the disease is colorectal cancer.